MedElevator Войти в исследования
← Поиск публикаций

DOI 10.3390/vaccines8020337

Медицинская библиотека · Vaccines · 2020

Features of the Human Antibody Response against the Respiratory Syncytial Virus Surface Glycoprotein G.

Borochova Kristina, Niespodziana Katarzyna, Stenberg Hammar Katarina, van Hage Marianne, Hedlin Gunilla, Söderhäll Cilla, Focke-Tejkl Margarete, Valenta Rudolf

СтатьяПеревод в очереди

Аннотация

Respiratory syncytial virus (RSV) infections are a major cause of serious respiratory disease in infants. RSV occurs as two major subgroups A and B, which mainly differ regarding the surface glycoprotein G. The G protein is important for virus attachment and G-specific antibodies can protect against infection. We expressed the surface-exposed part of A2 strain-derived G (A2-G) in baculovirus-infected insect cells and synthesized overlapping peptides spanning complete A2-G. The investigation of the natural IgG response of adult subjects during a period of one year showed that IgG antibodies (i) recognize G significantly stronger than the fusion protein F0, (ii) target mainly non-conformational, sequential peptide epitopes from the exposed conserved region but also buried peptides, and (iii) exhibit a scattered but constant recognition profile during the observation period. The IgG subclass reactivity profile (IgG1 > IgG2 > IgG4 = IgG3) was indicative of a mixed Th1/Th2 response. Two strongly RSV-neutralizing sera including the 1st WHO standard contained high IgG anti-G levels. G-specific IgG increased strongly in children after wheezing attacks suggesting RSV as trigger factor. Our study shows that RSV G and G-derived peptides are useful for serological diagnosis of RSV-triggered exacerbations of respiratory diseases and underlines the importance of G for development of RSV-neutralizing vaccines.

Для цитирования: Borochova Kristina, Niespodziana Katarzyna, Stenberg Hammar Katarina, van Hage Marianne, Hedlin Gunilla, Söderhäll Cilla, Focke-Tejkl Margarete, Valenta Rudolf. Features of the Human Antibody Response against the Respiratory Syncytial Virus Surface Glycoprotein G.. Vaccines. 2020. DOI: 10.3390/vaccines8020337.
Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.